Литература. 
Регуляторные пептиды

1. Алексеева ГВ, Ботаев НА, Горошкова ВВ. [Use of semax at a follow-up of patients with posthypoxic encephalopathy] Анастез реаним 1999;1:40−43.

2. Козловская ММ, Середенин СБ, Козловский ИИ, Е. А. Вальдман, ЛА. Андреева, Мясоедов НФ. Сравнительное изучение фрагментов тафтсина на показатели условной реакции пассивного избегания. Хим Фарм Журнал 2001;35(3):3−5.

3. Мясоедов НФ, Скворцова ВИ, Насонов ЕЛ, Журавлева ЕИ, Гривенников ИА, Арсеньева ЕЛ, Суханов ИИ. Исследование механизмов нейропротективного действия семакса в острый период ишемического инсульта. Журн неврол психиатр Корсак 1999;99(5):15−19.

4. Середенин CБ, Козловская ММ, Бледнов ИА, Козловский ИИ, Семенова ТП. и др. [The anxiolytic action of an analog of the endogenous peptide tuftsin on inbred mice with different phenotypes of the emotional stress reaction]. Журн высш нерв деят Павл 1998;48(1):153−160.

5. Яковлева ЕИ, Кузенков ВС, Федоров ВН, Скворцова ВИ, Koшелев ВБ, Гусев ЕИ, Ашмарин ИП. Исследование эффективности семакса при глобальной церебральной ишемии in vivo. Бюлл эксп биол мед 1999;127(8):172−174.

6. Abbott CR, Kennedy AR, Wren AM, Rossi M, Murphy KG, Seal LJ, Todd JF, ea Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormone. Endocrinology. 2003;144(9):3943−3949.

7. Abdelmalek Z. et al. Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. PNAS USA1995;92:1789.

8. Abramov AV, Kolesnik IuM. [Morphofunctional characteristics of gastrin-releasing peptide synthesizing system of the hypothalamus in normal conditions and in experimental diabetes in rats] Morfologiia. 2001;120(5):46−51.

9. Albrecht D, Broser M, Kruger H. Excitatory action of angiotensins II and IV on hippocampal neuronal activity in urethane anesthetized rats. Regul Pept 1997;70(2−3):105−109.

10. Amouyel P, Richard F, Cottel D. The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci Lett 1996;217:203−205.

11. Andoh T. et al. Nociceptin gene expression in rat dorsal root ganglia induced by peripheral inflammation. Neuroreport 1997;8(12):2793−2796.

12. Agrawal AK., Gupta CM. Tuftsin-bearing liposomes in treatment of macrophage-based infections. Adv Drug Deliv Rev 2000;41(2):135−146.

13. Arihara Z. et al. Immunoreactive orexin-A in human plasma. Peptides 2001;22(1):139−142.

14. Arletti R. et al. Aged rats are still responsive to the antidepressant and memory-improving effects of oxytocin/ Neuropeptides 1995;29(3):177−82.

15. Bari F. et al. Influence of hypoxia/ ischemia on cerebro-vascular responses to oxytocin in piglets. J Vasc Res1997;34(4):312−320.

16. Bashkatova VG, Koshelev VB, Fadyukova OE, Alexeev AA, Vanin AF, Rayevsky KS, Ashmarin IP, Armstrong DM. Novel synthetic analogue of ACTH 4−10 (Semax) but not glycine prevents the enhanced nitric oxide generation in cerebral cortex of rats with incomplete global ischemia Brain Res 2001;894(1):145−149.

17. Bastos R. et al. Alpha-adrenergic agonists inhibit the dipsogenic effect of angiotensin II by their stimulation of atrial natriuretic peptide release/ Brain Res 2001;895(1−2):80−88.

18. Benelli A. et al. Polymodal dose-response curve for oxytocin in the social recognition test. Neuropeptides 1995; 28(4):251−255.

19. Benoit A, Vargas MA, DesGroseillers L, Boileau G. Endothelin-converting enzyme-like 1 (ECEL1) is present both in the plasma membrane and in the endoplasmic reticulum Biochem J. 2004 Mar 1.

20. Benoit SC, Clegg DJ, Seeley RJ, Woods SC. Insulin and leptin as adiposity signals. Recent Prog Horm Res. 2004;59:267−85.

21. Bhattacharya SK. et al. Stress and water balance: the roles of ANP, AVP and isatin Indian J Exp Biol 1998; 36(12):1195−200.

22. Bielsky IF, Hu SB, Szegda KL, Westphal H, Young LJ. Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice. Neuropsychopharmacology. 2004;29(3):483−493.

23. Blanco M, Gallego R, Garcia-Caballero T, Dieguez C, Beiras A. Cellular localization of orexins in human anterior pituitary. Histochem Cell Biol. 2003;120(4):259−64.

24. Blevins JE, Eakin TJ, Murphy JA, Schwartz MW, Baskin DG. Oxytocin innervation of caudal brainstem nuclei activated by cholecystokinin. Brain Res. 2003;993(1−2):30−41.

25. Bull PM, Ludwig M, Blackburn-Munro GJ, Delgado-Cohen H, Brown CH, Russell JA. The role of nitric oxide in morphine dependence and withdrawal excitation of rat oxytocin neurons. Eur J Neurosci. 2003;18(9):2545−2551.

26. Braszko JJ, Kulakowska A, Winnicka MM, Karwowskapolecka W. CGP 42112A abolishes facilitation of recognition caused by angiotensin II and angiotensin II (3−7) in rats. Acta Neurobiol Exp 1997; 57:227−234.

27. Buwalda B. et al. Physiological and behavioral effects of chronic intracerebroventricular infusion of corticotropin-releasing factor in the rat. Psychoneuroendocrinol 1997;22(5):297−309.

28. Cameron VA. et al. C-type natriuretic peptide expression in olfactory regions of rat brain is modulated by acute water deprivation, salt loading and central angiotensin II. Neuroendocrinol 2001;73(1):46−53.

29. Campbell BM, Morrison JL, Walker EL, Merchant KM. Differential regulation of behavioral, genomic, and neuroendocrine responses by CRF infusions in rats. Pharmacol Biochem Behav. 2004;77(3):447−455.

30. Carr JA. Beta-endorphin inhibition of endogenous norepinephrine release from the A2 noradrenergic nucleus in vitro: Role of ?-opiate receptors and Na+ ion permeability. Brain Res Bull 1997; 44(1):19−23.

31. Carter SJ, Richardson CM, Wakerley JB. Excitatory effects of oxytocin and cholecystokinin on oxytocin neurones: differences between virgin, pregnant and lactating rats. Neurosci Lett. 2003;351(1):13−16.

32. Catania A. et al. The neuropeptide alpha-MSH has specific receptors on neutrophils and reduced chemotaxis in vitro. Peptides 1996;17(4):675−679;

33. Chabot JG, Juaneda C, Dumont Y, Fournier A, Quirion R. Evidence for the differential distribution of at least two adrenomedullin receptor subtypes in the rat brain. Scientific World Journal. 2001;1(12 Suppl 1):38.

34. Chang L, Ren Y, Liu X, Li WG, Yang J, Geng B, Weintraub NL, Tang C. Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart. J Cardiovasc Pharmacol. 2004;43(2):165−70.

35. Chodobski A. et al. The presence of arginine vasopressin and its mRNA in rat choroid plexus epithelium. Mol Brain Res 1997;48(1):67−72.

36. Chriguer J. et al. Hypothalamic atrial natriuretic peptide and secretion of oxytocin. Brain Res 2001;889(1−2):239−242.

37. Ciccocioppo R, Economidou D, Fedeli A, Angeletti S, Weiss F, Heilig M, Massi M. Attenuation of ethanol self-administration and of conditioned reinstatement of alcoholseeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats. Psychopharmacology (Berl). 2004;172(2):170−178.

38. Crawley J. Functional interactions of galanin and acetylcholin relevance to memory and Alzheimer disease. Behav. Brain Res. 1993; 57: 133.

39. Dauvilliers Y, Baumann CR, Carlander B, Bischof M, Blatter T, et al. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions J Neurol Neurosurg Psychiatry. 2003;74(12):1667−73.

40. Deguchi K, Sasaki I, Touge T, Tsukaguchi M, Takeuchi H, Kuriyama S. Abnormal baroreceptor-mediated vasopressin release as possible marker in early diagnosis of multiple system atrophy J Neurol Neurosurg Psychiatry. 2004;75(1):110−115.

41. Delalle I. et al. Laminar distribution of neuropeptide Y immunoreactive neurons in human prefrontal cortex during development. J Compar Neurology 1997;379 (4):515−522.

42. Dembinski A, Warzecha Z, Ceranowicz P, Tomaszewska R, Stachura J, Konturek SJ, Konturek PC. Ghrelin attenuates the development of acute pancreatitis in rat. J Physiol Pharmacol. 2003;54(4):561−73.

43. Depner UB, Reinscheid RK, Takeshima H, Brune K, Zeilhofer HU. Normal sensitivity to acute pain, but increased inflammatory hyperalgesia in mice lacking the nociceptin precursor polypeptide or the nociceptin receptor. Eur J Neurosci. 2003;17(11):2381−2387.

44. Derad I, Pietrowsky R, Dodt C. Enhanced psychophysiological signs of attention after ACEinhibition by captopril. Psychophysiol 1996;33:295−301.

45. Desprat C. & Zajac JM. Hypothermic effects of neuropeptide FF analogues in mice. Pharmacol Biochem Behav 1997;58(2):559−563.

46. Diaz E, Silva M, Israel A. Role of brain dopaminergic system in the adrenomedullin-induced diuresis and natriuresis. Pharmacol Res. 2003;48(5):489−96.

47. Drazen DL, Wortman MD, Schwartz MW, Clegg DJ, van Dijk G, Woods SC, Seeley RJ. Adrenalectomy alters the sensitivity of the central nervous system melanocortin system. Diabetes. 2003;52(12):2928−2934.

48. Dumont Y. et al. A selective CGRP (2) agonist, [Cys (Et)(2,7)]hCGRP — comparison in prototypical CGRP (1) and CGRP (2) in vitro bioassays. Can J Physiol Pharmacol 1997;75(6):671−676.

49. Dunzendorfer S, Feistritzer C, Enrich B, Wiedermann CJ. Neuropeptide-induced inhibition of IL-16 release from eosinophils. Neuroimmunomodulation. 2002;2003;10(4):217−23.

50. Dupouy V. & Zajac JM. Neuropeptide FF receptors control morphine-induced analgesia in the parafascicular nucleus and the dorsal raphe nucleus. Eur J Pharmacol 1997;330(2−3):129−137.

51. During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X, Bland RJ, et al. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med. 2003;9(9):1173−1179.

52. Duvauchelle et al. DAMGO and DPDPE facilitation of brain stimulation reward thresholds is blocked by the dopamine antagonist cis-flupenthixol. Neuropharmacology 1997; 36(8):1109−1114.

53. Dzaja A, Dalal MA, Himmerich H, Uhr M, Pollmacher T, Schuld A. Sleep enhances nocturnal plasma ghrelin levels in healthy subjects. Am J Physiol Endocrinol Metab. 2004 Feb 10/.

54. Eikelis N, Lambert G, Wiesner G, et al. Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function. Am J Physiol Endocrinol Metab. 2004 Jan 13.